4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-043713
President and COO sold 8,000 shares at an average $13.62 ($108,994)
- President and COO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Larson Tina Marriott · President and COO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $1.06 | $8,480 | 432,160 | D |
| 2023-07-27 | Sale : show line 2 in the form 10b5-1 | −3,627 | $13.12 | $47,570 | 428,533 | D |
| 2023-07-27 | Sale : show line 3 in the form 10b5-1 | −4,373 | $14.05 | $61,424 | 424,160 | D |
| Open-market sales · 8,000 sh · avg $13.62 · $108,994 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-07-29 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −8,000 | $1.06 | 2028-07-22 | 8,000 | 532,000 | D |
Loading xslF345X05/doc4.xml…